メニュー  → 生薬成分の代謝  → 
Saikosaponin b1
Saikosaponin b1

化合物名 Saikosaponin b1 
動物種 ヒト腸内細菌フローラ 
代謝パラメータ Oral administration
Oral administration
Oral administration
Oral administration
Oral administration
Oral administration
Oral administration
Oral administration
Oral administration
代謝物 Saikosaponin b1
Prosaikogenin A
Saikogenin A
関連生薬 柴胡 
参考文献 1) Kida H., Nakamura N., Meselhy M. R., Akao T. and Hattori M.: Isolation and identification of human intestinal bacteria capable of hydrolyzing saikosaponins. J. Trad. Med., 14, 34-40 (1997).

2) Kida H., Akao T., Meselhy M. R. and Hattori M.: Enzymes responsible for the metabolism of saikosaponins from Eubacterium sp. A-44, a human intestinal anaerobe. Biol. Pharm. Bull., 20, 1274-1278 (1997).

3) Kida H., Akao T., Meselhy M. R. and Hattori M.: Metabolism and pharmacokinetics of orally administered saikosaponin b1 in conventional, germ-free and Eubacterium sp. A-44 infected gnotobiote rats. Biol. Pharm. Bull., 21, 588-593 (1998). 
論文備考 ※Preparation of a bacterial suspension of human feces
Fresh feces obtained from a healthy young man (age : 25, male) were suspended in five volumes of phosphate buffer (pH 7.2). The fecal suspension thus obtained was used in the following experiments. [Kida et al., J. Trad. Med., 14, 34-40 (1997)]

※Time course of the metabolism of saikosaponin b1 by an intestinal bacterial suspension
GAM broth (9 ml) containing saikosaponin b1 (a final concentration, 1 mM) was incubated with an intestinal bacterial suspension (1 ml) in an anaerobic incubator at 37°C. A 100 μm portion was taken out at intervals (4, 10, 24 and 48 hours) and extracted with BuOH (100 μl). Five micro liters of the BuOH layer were applied to a TLC plate, which was developed with solvent system A. [Kida et al., J. Trad. Med., 14, 34-40 (1997)]